Search Results for 'Drug Discovery'
Contract Service Directory Companies
Featured Companies
View All Buyers Guide Companies »
Contract Service Directory Categories
View All Categories »
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
3P and Buzzard Pharmaceuticals Enter Cancer Collaboration
Enter into a partnership agreement for manufacturing of the potent IL-1 inhibitor Isunakinra.Charles Sternberg, Assistant Editor 05.07.21
-
Breaking News | Drug Development | R&D
Crown Bioscience Acquires OcellO
Expands its portfolio of in vitro services.Charles Sternberg, Assistant Editor 05.06.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Catalent Acquires Commercial-Scale Plasmid DNA Mfg. Facility
Promethera’s Hepatic Cell Therapy Support SA include's 32,400 sq.-ft. facility in Gosselies, Belgium.Kristin Brooks, Contract Pharma 05.06.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Novavax, Gavi Execute APA for COVID-19 Vax
Novavax to deliver 350 million doses beginning 3Q21.Kristin Brooks, Contract Pharma 05.06.21
-
Clinical Trials | Logistics | Supply Chain
LabConnect, Cryoport Partner to Support Triumvira Trial Logistics
Will integrate Cryoport's Cryoportal Logistics Management Platform and LabConnect's SampleGISTICS platform to provide Triumvira with advanced logistics support.Kristin Brooks, Contract Pharma 05.06.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
ADC Therapeutics Receives FDA Approval for Zynlonta
ADC collaborated with Sterling Pharma Solutions to develop Zynlonta.Charles Sternberg, Assistant Editor 05.06.21
-
Breaking News | Drug Delivery | Drug Development | Industry News
Vectura, Inspira Partner to Develop Inhaled COVID Treatment
Further testing and development work to prepare for Phase 1 studies using its FOX vibrating mesh nebulizer to deliver IPX formulations.Kristin Brooks, Contract Pharma 05.06.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Richter-Helm Triples cGMP Production Capacity
Will invest close to €70 million to triple current biologic production capacity and expand existing warehouse, lab, and administration buildings.Kristin Brooks 05.06.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Lonza Expanding Next-Gen Mammalian Mfg. Facilities
Will invest approximately CHF 850 million to build two new state-of-the-art mammalian facilities in Visp and Portsmouth, U.S.Kristin Brooks 05.06.21
-
Analytical Services
Too Much of a Good Thing?
Watch out for that pendulum!Emil W. Ciurczak, DoraMaxx Consulting 05.05.21
-
Analytical Services | Laboratory Testing
Dissolution Development
Fast track methodology for your highly soluble, highly permeable drug.Melissa Nelson and Caitlin White, Metrics Contract Services 05.05.21
-
Biologics, Proteins, Vaccines
Gene Therapy Manufacturing Trends
Accelerating the path to industrialized gene therapy manufacturing with high capacity, scalable, fixed-bed bioreactors.Alex Chatel, Product Manager for Viral Applications, Univercells Technologies 05.05.21
-
Analytical Services | Clinical Trials | Information Technology
Implications of COVID-19 on Statistical Design and Analyses of Clinical Studies
A look at the challenges and risks to statistical integrity and how they can be mitigated.Tim Victor, Head of Biostatistics, Clinical Research Services, ICON plc 05.05.21
-
Biologics, Proteins, Vaccines
Overcoming AAV Manufacturing Challenges
Disruptive technologies and advances in analytics are needed to enable wider application of gene therapies in a cost effective and sustainable way.Sybil Danby, Senior Vice President of Business Development and Strategy, Center for Breakthrough Medicines 05.05.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Clean Biologics Acquires Biodextris
To establish North American presence and expand activities with Biodextris’ complementary services.Tim Wright, Editor, Contract Pharma 05.05.21
-
Breaking News | Drug Development | Industry News
Exelixis Acquires GamaMabs Oncology Antibody Program
Gains AMHR2 franchise technology including all assets pertaining to GamaMabs’ monoclonal antibody drug product murlentamab.Kristin Brooks 05.04.21
-
Breaking News | Clinical Trials | CRO News | Information Technology
Syneos, Komodo Health Expand Data App Alliance
Leveraging Komodo’s Healthcare Map, Syneos aims to better analyze clinical, real-world, and commercial data.Kristin Brooks 05.04.21
-
Clinical Trials | Information Technology | Promotions & Moves
Clinical Ink Adds Executives
CCO Chris Crucitti, COO Brian Donahue, and VP Project Operations Bill Barrasso to manage eSource platforms.Kristin Brooks 05.04.21
-
Breaking News | cGMP Manufacture | Industry News | Information Technology
Autolomous to Expedite Digitization of Batch Verification
Will work to develop AutoloMATE-Assist, a digital batch verification technology for cell and gene therapies to alleviate paper based bottlenecks.Kristin Brooks 05.04.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Moderna to Increase Global Supply for COVID-19 Vaccine
Will supply up to 3 billion doses in 2022 and double supply from ex-U.S. supply chain.Tim Wright, Editor, Contract Pharma 05.03.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News
Sanofi, Moderna Enter COVID-19 Vaccine Fill/Finish Manufacturing Deal
Sanofi will provide fill/finish services for up to 200 million doses of Moderna’s COVID-19 vaccine in the U.S. beginning in September 2021.Tim Wright, Editor, Contract Pharma 05.03.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News | R&D
Albumedix Extends Research Collaboration with Cobra Biologics
Collaboration investigates enhanced manufacturing of AAV and lentiviral vectors to improve quality and productivity for gene therapy and vaccine developers.Tim Wright, Editor, Contract Pharma 05.03.21
-
Bio News | Breaking News | Drug Development | Drug Discovery | Facilities | Industry News | Information Technology
AbCellera Breaks Ground on Global HQ in Vancouver
380,000 square feet of facilities envisioned as creative tech hub expected to be completed in 2023 and 2024.Tim Wright, Editor, Contract Pharma 05.03.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
CCRM and Amgen Partner to Advance Emerging Medical Innovations
New fund to support regenerative medicine discoveries with high potential impact for patients.Tim Wright, Editor, Contract Pharma 05.03.21
-
Analytical Services | Bioanalytical Services | Breaking News | cGMP Manufacture | Drug Development | Industry News | R&D
AMRI Adds R&D and Mfg. Solutions for Orphan Products
Targeted investments globally expand scale and compound handling capabilities at facilities in Albany, Grafton, and Glasgow.Kristin Brooks 04.30.21
-
APIs | Capsules | Formulation Development
How to Achieve Precise and Flexible Dosing with Multiparticulates
Multiparticulate systems have several advantages over conventional tablet or capsule formulations. Download this whitepaper to learn more.
-
Formulation Development
Melt Extrusion and How Helps Advance New Medicines
Bernd Liepold, Ph.D. of AbbVie explains melt extrusion and how it works in the formulation of new medicines.Videos
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
GenScript Launches Research Lentiviral Vector Packaging Service
Enables scientists to package their genetic material of choice to ensure consistent production of functional and intact viruses.Charles Sternberg, Assistant Editor 04.29.21
-
Analytical Services | Bioanalytical Services | Breaking News | CRO News | Facilities | Industry News
PPD to Expand GMP Lab in Ireland
Adding cell and gene therapy capabilities to support growing customer need.Tim Wright, Editor, Contract Pharma 04.29.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News | Validation
ADMA Receives FDA Approval for Increased IVIG Production Scale
Increases plant manufacturing capacity from 400,000L to 600,000L.Tim Wright, Editor, Contract Pharma 04.29.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Lonza Doubles Drug Substance Production for Moderna’s COVID-19 Vaccine
New agreement for three additional production lines at Lonza’s site in Visp, Switzerland.Tim Wright, Editor, Contract Pharma 04.29.21
-
Breaking News | Clinical Trials | Drug Development | Industry News
Pfizer Acquires Amplyx Pharmaceuticals
Deal expands anti-infectives pipeline with addition of novel antifungal Phase 2 candidate, Fosmanogepix (APX001).Tim Wright, Editor, Contract Pharma 04.29.21
-
Clinical Trials | CRO News | Information Technology
PPD, Science 37 Partner to Advance Decentralized Trials
PPD will leverage Science 37's DCT SaaS-based technology platform to design, build, test, implement and execute digital trials.Kristin Brooks 04.28.21
-
Breaking News | Drug Development
Silo Pharma Enters Joint Venture with Zylo Therapeutics
Will explore the clinical development of ketamine and psilocybin using ZTI’s Z-pod technology.Charles Sternberg, Assistant Editor 04.28.21
-
Biologics, Proteins, Vaccines | Breaking News
Introducing ViroCell Biologics
The UK’s first clinical trial focused viral vector manufacturer.Charles Sternberg, Assistant Editor 04.28.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Laboratory Testing
Syngene, BMS Extend Long Term Research Alliance until 2030
Extension will include a 40% increase in the number of scientists and the addition of a new 50,000 sq.-ft. dedicated lab space.Kristin Brooks 04.28.21
-
Breaking News | Industry News | Preclinical Outsourcing
Charnwood Molecular Plans Significant Expansion
Partnered with private equity fund Synova to provide the capital to support additional high-value research capabilities.Kristin Brooks 04.28.21
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development
AavantiBio, Catalent Enter Gene Therapy Alliance
Aims to advance AavantiBio’s gene therapy pipeline, including its lead program in Friedreich’s Ataxia (FA)Kristin Brooks 04.28.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Samsung Biologics, TG Therapeutics Expand Manufacturing Collaboration
Expands existing contract manufacturing deal to further enable global manufacture of ublituximab.Tim Wright, Editor, Contract Pharma 04.27.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Bristol Myers Squibb Invests in Cell Therapy Ops
New manufacturing site planned in the Netherlands is the company’s fifth facility dedicated to cell therapy.Tim Wright, Editor, Contract Pharma 04.27.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
RDIF, Minapharm to Make Over 40M Doses of the Sputnik V Vaccine in Egypt
Production will take place in Minapharm’s biotech facility in Cairo for global distribution.Tim Wright, Editor, Contract Pharma 04.23.21
-
Breaking News | Collaborations & Alliances | Drug Development | Formulation Development
Nanoform, Aprecia Partner to Advance 3DP Nanomedicines
To explore synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms.Kristin Brooks 04.22.21
-
Breaking News | Drug Development | Drug Discovery
KemPharm Receives $10M Milestone for FDA Approval of Azstarys
Is eligible to receive an additional near-term $10 million milestone payment following DEA scheduling of SDX.Charles Sternberg, Assistant Editor 04.22.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax
Looks to secure a supply agreement for the only inactivated vaccine candidate in clinical trials against COVID-19 in EU.Kristin Brooks 04.22.21
-
Clinical Trials | CRO News | Information Technology
Syneos, Medable Partner for New Decentralized Capabilities
Aims to increase clinical trial diversity and improve patient access and experiences with fit-for-purpose decentralized digital solution.Kristin Brooks 04.22.21
-
Biologics, Proteins, Vaccines | Clinical Trials | Trials & Filings
Valneva’s Inactivated, Adjuvanted COVID-19 Vax Achieves Positive Data
VLA2001 was highly immunogenic with more than 90% of study participants developing significant levels of antibodies to SARS-CoV-2 virus spike protein.Kristin Brooks 04.22.21
-
Clinical Trials | R&D | Regulatory Affairs
Unifying Quality Manufacturing to Drive Speed, Collaboration, and Compliance
Learn how you can unify end-to-end quality management to improve visibility, efficiency, and compliance in this webinar on May 13.04.22.21
-
Clinical Trials
Decentralized Clinical Trials: The 101 on Digital Health Technologies (DHTs)
The huge uptick in decentralized trials this past year has greatly increased the use of digital health technologies (DHTs).
-
Drug Development
Lessons Learned: Choosing and Managing a CDMO
This webinar on May 25 covers how putting the right parameters in place at the beginning of a client-CDMO relationship reduces risk and improves communications.04.21.21
-
Bio News | Bioanalytical Services | Breaking News | Industry News
Waters and Genovis Enter Biopharmaceutical Partnership
Collaboration intended to bring speed and simplicity to bio-characterization workflows.Tim Wright, Editor, Contract Pharma 04.21.21
